But initial results were disappointing
Insurance coverage for GLP-1 medications varies significantly depending on your specific plan
In short, there are several reasons why more people and providers are experimenting with microdosing, ranging from cost and access challenges to adverse side effects at standard doses, as well as off-label uses such as appetite suppression, management of acute and chronic inflammation, impulse control, and adjunctive support in type 1 diabetes
This article explains what triple agonist peptides are, how they differ from the single and dual agonist compounds that preceded them, what the term "GLP-3" refers to (and what it doesn't), and what Canadian researchers entering this category should understand before evaluating specific compounds
While GLP-1s are effective for weight loss, they are not clinically appropriate for everyone
If you need more blood sugar control after 60 days, your provider will have you increase to 14 mg